US$ 26.21
foxo4-dri human trial senolytic Peptide Senolytic Peptide FOXO4-DRI Selectively Removes
Description
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference

"Rybelsus Summary of Product Characteristics (SmPC)"

98% purity verified by HPLC

Citations [1] Sun X, Deng Y, Fu X, Wang S, Duan R, Zhang Y
